ArticleTheranostics2021

CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.

Wenzhi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.